![]() Bausch + Lomb acquires XIIDRA eye drops, delivery system from Novartis in $2.The biggest stories from the American Diabetes Association (ADA) 2023 Scientific Sessions.When it comes to sales, medical device teams are capable of so much more.ReWalk Robotics, Myomo to benefit from new proposed Medicare classifications.Xtant Medical announces $15M private placement.Study backs Lunit’s AI-powered cancer diagnostics.We will continue to vigorously protect our innovative products, solutions and intellectual property,” said Chris Barry, Covidien’s advanced surgical technologies president, in prepared remarks.įiled Under: Legal News, News Well, Patent Infringement, Surgical Tagged With: Covidien, Ethicon, Johnson and Johnson, Tyco Healthcare ![]() ![]() We are pleased that the federal court recognized our innovation in ultrasonic surgical devices, finding our patents both valid and infringed by Ethicon Endo-Surgery. “As a global healthcare market leader, Covidien invests significant resources into creating and developing medical innovations. The royalty damages were $140.1 million and the prejudgment interest amounted to $36.4 million, according to court documents. "Tyco is entitled to 8% royalty damages and 3.25% prejudgment interest for damages in the total amount of $176,500,800.00."Īrterton decided that the infringing sales by Ethicon from April 1, 2004, to March 31, 2012, amounted to $1.75 billion, using that figure to calculate the damages. designs, manufactures, and distributes medical devices. "he evidence presented at trial shows that Tyco’s and Ethicon’s advanced energy products directly competed with each other," Arterton wrote. Surgical Corp., with products including its Autosonix and LCS ultrasonic scalpels (Covidien’s competing products include its Harmonic Shears, according to the court documents).Ĭovidien "proved infringement of all asserted claims of the patents in suit" but failed to prove willful infringement (closing the door on the possibility of triple damages) and isn’t entitled to lost profits damages or a preliminary injunction, Arterton wrote, according to the documents. Judge Janet Bond Arterton ruled that Ethicon Endo-Surgery infringed 6 claims in 3 patents held by Covidien’s corporate predecessors, Tyco Healthcare and U.S. Consignees were instructed: DO NOTt use product from the affected lots, but implanted devices do not need to be removed as part of this recall. UPDATED March 29, 2013, with comment from Covidien.Ĭovidien (NYSE: COV) won a nearly $177 million victory yesterday over Johnson & Johnson‘s (NYSE: JNJ) Ethicon Endo-Surgery subsidiary in a patent war over ultrasonic scalpel technology. Ethicon Endo-Surgery issued an Urgent : Devoced Recall Event 2240 letter dated Octoto all consignees identifying the affected devices and actions to be taken.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |